{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T02:35:34Z","timestamp":1772678134254,"version":"3.50.1"},"reference-count":15,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Indian Journal of Tuberculosis"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.ijtb.2021.05.002","type":"journal-article","created":{"date-parts":[[2021,5,29]],"date-time":"2021-05-29T10:43:19Z","timestamp":1622284999000},"page":"325-333","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Cyclophosphamide therapy as an adjunct in refractory post-tubercular arachnoiditis"],"prefix":"10.1016","volume":"69","author":[{"given":"Vinay","family":"Goyal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arunmozhimaran","family":"Elavarasi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anand","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priyanka","family":"Samal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9385-291X","authenticated-orcid":false,"given":"Ajay","family":"Garg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Garima","family":"Shukla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.Y.","family":"Vishnu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mamta Bhushan","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.V. Padma","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ijtb.2021.05.002_bib1","doi-asserted-by":"crossref","first-page":"37","DOI":"10.4103\/aian.AIAN_70_18","article-title":"Practice trends in treating central nervous system tuberculosis and outcomes at a tertiary care hospital: a cohort study of 244 cases","volume":"22","author":"Goyal","year":"2019","journal-title":"Ann Indian Acad Neurol"},{"issue":"9","key":"10.1016\/j.ijtb.2021.05.002_bib2","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1586\/eri.11.93","article-title":"Tuberculous optochiasmatic arachnoiditis: a devastating form of tuberculous meningitis","volume":"9","author":"Garg","year":"2011","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"3 Pt 1","key":"10.1016\/j.ijtb.2021.05.002_bib3","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1164\/ajrccm.157.3.9708002","article-title":"The host immune response to tuberculosis","volume":"157","author":"Schluger","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"10.1016\/j.ijtb.2021.05.002_bib4","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1086\/592695","article-title":"Therapeutic use of infliximab in tuberculosis to control severe paradoxical reaction of the brain and lymph nodes","volume":"47","author":"Blackmore","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"1\u20132","key":"10.1016\/j.ijtb.2021.05.002_bib5","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jns.2014.03.025","article-title":"Paradoxical reaction in HIV negative tuberculous meningitis","volume":"340","author":"Garg","year":"2014","journal-title":"J Neurol Sci"},{"issue":"4","key":"10.1016\/j.ijtb.2021.05.002_bib6","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/IPC.0000000000000883","article-title":"Intrathecal hyaluronidase in tubercular arachnoiditis: the unexplored adjuvant","volume":"28","author":"Samal","year":"2020","journal-title":"Infect Dis Clin Pract"},{"issue":"4","key":"10.1016\/j.ijtb.2021.05.002_bib7","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1177\/088307380401900402","article-title":"Adjunctive thalidomide therapy for childhood tuberculous meningitis: results of a randomized study","volume":"19","author":"Schoeman","year":"2004","journal-title":"J Child Neurol"},{"issue":"16","key":"10.1016\/j.ijtb.2021.05.002_bib8","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1212\/WNL.0b013e318250d84a","article-title":"Cyclophosphamide treatment\u00a0for unrelenting CNS vasculitis secondary to tuberculous meningitis","volume":"78","author":"Gonzalez-Duarte","year":"2012","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.ijtb.2021.05.002_bib9","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1080\/23744235.2018.1467038","article-title":"Cyclophosphamide immunomodulation of TB-associated cerebral vasculitis","volume":"50","author":"Celotti","year":"2018","journal-title":"Infect Dis"},{"issue":"2","key":"10.1016\/j.ijtb.2021.05.002_bib10","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0962-8479(94)90045-0","article-title":"Diagnostic criteria for tuberculous meningitis and their validation","volume":"75","author":"Ahuja","year":"1994","journal-title":"Tuber Lung Dis"},{"issue":"6","key":"10.1016\/j.ijtb.2021.05.002_bib11","doi-asserted-by":"crossref","first-page":"915","DOI":"10.4103\/0028-3886.91384","article-title":"Idiopathic hypertrophic pachymeningitis successfully treated with intravenous cyclophosphamide","volume":"59","author":"Zhuoyou","year":"2011","journal-title":"Neurol India"},{"issue":"29","key":"10.1016\/j.ijtb.2021.05.002_bib12","doi-asserted-by":"crossref","first-page":"e11186","DOI":"10.1097\/MD.0000000000011186","article-title":"Intracranial tuberculous mass lesions treated with thalidomide in an immunocompetent child from a low tuberculosis endemic country: a case report","volume":"97","author":"Caraffa","year":"2018","journal-title":"Medicine (Baltim)"},{"issue":"12","key":"10.1016\/j.ijtb.2021.05.002_bib13","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1136\/ard.2010.130476","article-title":"EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs","volume":"69","author":"Bertsias","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.ijtb.2021.05.002_bib14","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1001\/archneur.1988.00520250033014","article-title":"Controlled pilot trial of monthly intravenous cyclophosphamide in multiple sclerosis","volume":"45","author":"Killian","year":"1988","journal-title":"Arch Neurol"},{"issue":"6","key":"10.1016\/j.ijtb.2021.05.002_bib15","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1002\/art.39068","article-title":"Adult primary central nervous system vasculitis treatment and course: analysis of one hundred sixty-three patients","volume":"67","author":"Salvarani","year":"2015","journal-title":"Arthritis Rheumatol"}],"container-title":["Indian Journal of Tuberculosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0019570721001049?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0019570721001049?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T03:59:40Z","timestamp":1758081580000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0019570721001049"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S0019570721001049"],"URL":"https:\/\/doi.org\/10.1016\/j.ijtb.2021.05.002","relation":{},"ISSN":["0019-5707"],"issn-type":[{"value":"0019-5707","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cyclophosphamide therapy as an adjunct in refractory post-tubercular arachnoiditis","name":"articletitle","label":"Article Title"},{"value":"Indian Journal of Tuberculosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijtb.2021.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Tuberculosis Association of India. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}